464 related articles for article (PubMed ID: 26311528)
21. A Strategy of Underexpansion and Ad Hoc Post-Dilation of Balloon-Expandable Transcatheter Aortic Valves in Patients at Risk of Annular Injury: Favorable Mid-Term Outcomes.
Tan JS; Leipsic J; Perlman G; Stub D; Dvir D; Hansson NC; Norgaard BL; Blanke P; Cheung A; Ye J; Thompson CR; Moss RR; Lauck S; Wood D; Webb J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1727-32. PubMed ID: 26476612
[TBL] [Abstract][Full Text] [Related]
22. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
[TBL] [Abstract][Full Text] [Related]
23. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
[TBL] [Abstract][Full Text] [Related]
24. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
Abdel-Wahab M; Mehilli J; Frerker C; Neumann FJ; Kurz T; Tölg R; Zachow D; Guerra E; Massberg S; Schäfer U; El-Mawardy M; Richardt G;
JAMA; 2014 Apr; 311(15):1503-14. PubMed ID: 24682026
[TBL] [Abstract][Full Text] [Related]
25. Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience.
Diemert P; Lange P; Greif M; Seiffert M; Conradi L; Massberg S; Blankenberg S; Reichenspurner H; Hagl C; Schmitz C; Schröfel H; Treede H; Schymik G; Kupatt C
Clin Res Cardiol; 2014 Mar; 103(3):183-90. PubMed ID: 24249313
[TBL] [Abstract][Full Text] [Related]
26. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation.
Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664
[TBL] [Abstract][Full Text] [Related]
27. Is postdilatation useful after implantation of the Edwards valve?
Watanabe Y; Hayashida K; Lefèvre T; Romano M; Hovasse T; Chevalier B; Garot P; Donzeau-Gouge P; Farge A; Bouvier E; Cormier B; Morice MC
Catheter Cardiovasc Interv; 2015 Mar; 85(4):667-76. PubMed ID: 24659083
[TBL] [Abstract][Full Text] [Related]
28. Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement.
Martinez CA; O'Neill B; Singh V; O'Neill WW
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E587-91. PubMed ID: 23008182
[TBL] [Abstract][Full Text] [Related]
29. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.
Blumenstein JM; Van Linden A; Moellmann H; Seeburger J; Rastan A; Kim WK; Mohr FW; Kempfert J; Walther T
Thorac Cardiovasc Surg; 2013 Aug; 61(5):409-13. PubMed ID: 23247690
[TBL] [Abstract][Full Text] [Related]
30. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience.
Abdel-Wahab M; Comberg T; Büttner HJ; El-Mawardy M; Chatani K; Gick M; Geist V; Richardt G; Neumann FJ;
JACC Cardiovasc Interv; 2014 Mar; 7(3):284-92. PubMed ID: 24650401
[TBL] [Abstract][Full Text] [Related]
31. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).
Chieffo A; Buchanan GL; Van Mieghem NM; Tchetche D; Dumonteil N; Latib A; van der Boon RM; Vahdat O; Marcheix B; Farah B; Serruys PW; Fajadet J; Carrié D; de Jaegere PP; Colombo A
J Am Coll Cardiol; 2013 Feb; 61(8):830-6. PubMed ID: 23333140
[TBL] [Abstract][Full Text] [Related]
32. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
33. Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement With the Self-Expanding CoreValve Versus the Balloon-Expandable SAPIEN XT Valve.
Kiramijyan S; Magalhaes MA; Koifman E; Didier R; Escarcega RO; Baker NC; Negi SI; Minha S; Torguson R; Jiaxiang G; Asch FM; Wang Z; Okubagzi P; Gaglia MA; Ben-Dor I; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2016 May; 117(9):1502-10. PubMed ID: 26996768
[TBL] [Abstract][Full Text] [Related]
34. Clinical profile and outcome of patients with severe aortic stenosis at high surgical risk: single-center prospective evaluation according to treatment assignment.
Dvir D; Sagie A; Porat E; Assali A; Shapira Y; Vaknin-Assa H; Shafir G; Bental T; Nevzorov R; Battler A; Kornowski R
Catheter Cardiovasc Interv; 2013 Apr; 81(5):871-81. PubMed ID: 22915555
[TBL] [Abstract][Full Text] [Related]
35. Balloon-expandable prostheses for transcatheter aortic valve replacement.
Ribeiro HB; Urena M; Allende R; Amat-Santos IJ; Rodés-Cabau J
Prog Cardiovasc Dis; 2014; 56(6):583-95. PubMed ID: 24838134
[TBL] [Abstract][Full Text] [Related]
36. Edwards SAPIEN 3 valve.
Binder RK; Rodés-Cabau J; Wood DA; Webb JG
EuroIntervention; 2012 Sep; 8 Suppl Q():Q83-7. PubMed ID: 22995118
[TBL] [Abstract][Full Text] [Related]
37. Major thrombocytopenia after balloon-expandable transcatheter aortic valve replacement: prognostic implications and comparison to surgical aortic valve replacement.
Jilaihawi H; Doctor N; Chakravarty T; Kashif M; Mirocha J; Cheng W; Lill M; Nakamura M; Gheorghiu M; Makkar RR
Catheter Cardiovasc Interv; 2015 Jan; 85(1):130-7. PubMed ID: 24677617
[TBL] [Abstract][Full Text] [Related]
38. Predictors and clinical impact of pre-existing and acquired thrombocytopenia following transcatheter aortic valve replacement.
Flaherty MP; Mohsen A; Moore JB; Bartoli CR; Schneibel E; Rawasia W; Williams ML; Grubb KJ; Hirsch GA
Catheter Cardiovasc Interv; 2015 Jan; 85(1):118-29. PubMed ID: 25204308
[TBL] [Abstract][Full Text] [Related]
39. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
[TBL] [Abstract][Full Text] [Related]
40. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
